Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect our body? And what's left to learn?
The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...
Nearly 4.4 million adult New Yorkers, or 30%, have obesity, but access to weight-loss medications varies based on a variety ...
If you’re taking semaglutide for diabetes or weight loss, a new once-a-month injection could soon make it easier to stick to ...
Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...
Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight ...
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...
Doctors are sending out a warning after children as young as 10 years old are using drugs like Ozempic and Wegovy.